[1]
M. Cozzolino, S. Pasho, C. Crovetto, and E. Missaglia, “Treatment of secondary hyperparathyroidism: calcimimetics, selective activators of vitamin D receptor (VDRAs) or combination therapy?”, G Clin Nefrol Dial, vol. 19, no. 3-4, pp. 28–33, Jul. 2007.